Tekmira plans NASDAQ listing

Tekmira Pharmaceuticals (TSX:TKM) plans to apply to list its common shares on the Nasdaq stock market in the next few months. “Many of our peers have securities listed in the U.S. and we believe doing so is a logical step in the evolution of Tekmira to be appropriately valued as a leader in the RNA [...]

Migenix names Brennan as CEO

Vancouver-based Migenix (TSX:MGI) has appointed Paul Brennan as CEO, effective immediately, succeeding interim president and CEO Bruce Schmidt, who will continue as president. Mr. Brennan has more than 20 years of pharma and biotech experience, including most recently as CEO of Altair Therapeutics of San Diego. He also has held senior executive positions with Aspreva [...]

Stellar’s Uracyst praised at urology conference

A leading Canadian urologist and researcher gave a positive presentation of Stellar Pharmaceuticals’ Uracyst drug at an American Urology Association conference in Montreal last week, citing results of two studies that showed improved symptoms in patients with interstitial cystitis/painful bladder syndrome (IC/PBS). Dr. Curtis Nickel of Queen’s University said a “larger multi-centre, placebo controlled study [...]